Keyphrases
Asthma
83%
Inhaled Corticosteroids
50%
Fluticasone Propionate
27%
Forced Expiratory Volume in 1 Second (FEV1)
26%
Chronic Obstructive Pulmonary Disease
25%
Allergic Rhinitis
25%
Impulse Oscillometry
22%
Spirometry
22%
Placebo
21%
Persistent Asthma
18%
Beta-blockers
17%
Asthmatic
16%
Airway Hyperresponsiveness
15%
Lung Function
15%
Fractional Exhaled Nitric Oxide (FeNO)
15%
Salmeterol
15%
Asthma Control
14%
Severe Asthma
13%
Budesonide
12%
Asthma Exacerbation
12%
Methacholine
12%
Confidence Interval
12%
Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
11%
Hydrofluoroalkane
11%
Metered Dose Inhaler
10%
Rhinitis
10%
Moderate to Severe
9%
Genotype
9%
Salbutamol
9%
Airway
9%
Mannitol
9%
Asthma Patients
8%
High Dose
8%
Asthma Symptoms
8%
Bronchoconstriction
8%
Oscillometry
7%
Peak Nasal Inspiratory Flow
7%
Nasal
7%
Exhaled Nitric Oxide
7%
COVID-19
7%
Healthy Volunteers
7%
Monotherapy
7%
Asthma Phenotypes
7%
Small Airways
7%
Proof of Concept Study
7%
Benralizumab
7%
Tiotropium
6%
Reactance
6%
Quality of Life
6%
Long-acting beta-agonists
6%
Pharmacology, Toxicology and Pharmaceutical Science
Asthma
100%
Chronic Obstructive Lung Disease
40%
Placebo
24%
Allergic Rhinitis
15%
Metered-Dose Inhaler
15%
Fluticasone
15%
Salbutamol
14%
Beta Adrenergic Receptor Blocking Agent
14%
Fluticasone Propionate
13%
Respiratory Tract Allergy
13%
Salmeterol
12%
Fluorinated Hydrocarbon
10%
Hydrocortisone
10%
Nitric Oxide
9%
Beta Adrenergic Receptor Stimulating Agent
9%
Mannitol
9%
Budesonide
9%
Methacholine
9%
Diseases
8%
Inflammation
7%
Bioavailability
7%
Bronchodilating Agent
7%
Randomized Controlled Trial
6%
Creatinine
6%
Anti-Inflammatory Drug
6%
Bisoprolol
6%
Muscarinic Receptor Blocking Agent
6%
Adrenergic Receptor
6%
Monotherapy
5%
Beta 2 Adrenergic Receptor Stimulating Agent
5%
Adenosine Phosphate
5%
Beclometasone Dipropionate
5%
Cohort Study
5%
Pollen Allergy
5%
Rhinitis
5%
Formoterol Fumarate Plus Glycopyrronium Bromide
5%
Beclometasone
5%
Medicine and Dentistry
Asthma
63%
Chronic Obstructive Pulmonary Disease
30%
Oscillometry
21%
Allergic Rhinitis
19%
Nitric Oxide
18%
Placebo
13%
Spirometry
13%
Nasal Polyp
12%
Chronic Rhinosinusitis
12%
Severe Asthma
11%
Lung
11%
Diseases
10%
Rhinitis
10%
Airway Resistance
8%
Biological Product
7%
Beta Adrenergic Receptor Stimulating Agent
7%
Quality of Life
6%
Respiratory Tract Allergy
6%
Beta Adrenergic Receptor Blocking Agent
6%
Topical Corticosteroid
6%
Benralizumab
6%
Forced Expiratory Volume
6%
Patient with Asthma
5%
Arterial Stiffness
5%